Abstract:Rationale: Enhancer RNA (eRNA) bi-directionally expresses from enhancer region and sense eRNA regulates adjacent mRNA in cis and in trans. However, it has remained unclear whether antisense eRNAs in different direction are functional or merely a reflection of enhancer activation.Methods: Strand-specific, ribosome-minus RNA sequencing (RNA-seq) were performed in AR positive prostate cancer cells. RNA-seq, GRO-seq, ChIP-seq, 4C-seq and DNA-methylation-seq that published in our and other labs were re-analyzed to define bi-directional enhancer RNA and DNA methylation regions. Molecular mechanisms were demonstrated by 3C, ChIP, ChIRP, CLIP, RT-PCR and western blot assays. The biological functions of antisense-eRNA were assessed using mice xenograft model and RT-PCR analysis in human tissues.Results: In this study, we identified that antisense eRNA was regulated by androgen receptor (AR) activity in prostate cancer cells. Antisense eRNA negatively regulated antisense ncRNA in AR-related target genes' loci, through recruiting DNMT1 on the antisense enhancer in the gene-ending regions and elevating DNA methylation. Importantly, the chromatin exhibited a double looping manner that facilitated sense-eRNA to promoter and antisense-eRNA to gene-ending region in cis. Depletion of antisense eRNA impaired its neighbor mRNA expression, cancer growth and invasion. The expressions of antisense eRNA were correlated with biochemical recurrence and clinical marker PSA's levels in patients' tissues.Conclusions: The findings indicated that antisense eRNA was a functional RNA and may be a novel target that when suppressed improved prostate cancer therapy and diagnosis. New chromatin interaction among enhancer, promoter and gene-ending region might provide new insight into the spatiotemporal mechanism of the gene transcription and acting of bi-directional eRNAs.

Transcriptional Regulation of E-cadherin by Small Activating RNA: A New Double-Stranded RNA.

Up-regulation of E-cadherin by Small Activating RNA Inhibits Cell Invasion and Migration in 5637 Human Bladder Cancer Cells

Small Activating RNA Modulation of the G Protein‐Coupled Receptor for Cancer Treatment

Suppression of Migration and Invasion of PC3 Prostate Cancer Cell Line Via Activating E-Cadherin Expression by Small Activating RNA

Small RNA-induced INTS6 gene up-regulation suppresses castration-resistant prostate cancer cells by regulating β-catenin signaling.

Functional roles of antisense enhancer RNA for promoting prostate cancer progression

Target-Recognition Mechanism and Specificity of RNA Activation.

Small Activating Rna Binds to the Genomic Target Site in A Seed-Region-Dependent Manner

Promoter-targeted Double-Stranded Small RNAs Activate PAWR Gene Expression in Human Cancer Cells

Genetic and Epigenetic Regulation of E-Cadherin Signaling in Human Hepatocellular Carcinoma.

Systematic functional characterization of antisense eRNA of protocadherin α composite enhancer

[Antitumor Effect of Epidermal Growth Factor Receptor Gene Silencing].

Enhancer RNA (eRNA) in Human Diseases

Mechanisms Involved in the Activation of C/EBPα by Small Activating RNA in Hepatocellular Carcinoma.

A Small Molecule Enhances RNA Interference and Promotes Microrna Processing

A novel transcriptional complex on the VE-cadherin promoter regulated the downregulation of VE-cadherin in the Down Syndrome Candidate Region 1 isoform 1L-mediated angiogenesis

Targeting ETS1 with RNAi-based Supramolecular Nanoassemblies for Multidrug-Resistant Breast Cancer Therapy.

Antitumor effect of RNA interference on non-small cell lung cancer in vivo

Antitumor Effect of RNA Interference on Non-Small-cell Lung Cancer in Vivo

saRNA-guided Ago2 targets the RITA complex to promoters to stimulate transcription